DETECTION OF HBV-RELATED DNA AND VIRAL-PROTEINS IN THE KIDNEYS OF A LIVER-TRANSPLANT RECIPIENT

被引：0
|
作者：
YOFFE, B
EIGENBRODT, EH
CLARK, JH
WOOD, RP
HAN, KH
NOONAN, CA
TANDON, AK
GENTA, RM
机构：
[1] UAMC,HOUSTON,TX
[2] BAYLOR COLL MED,HOUSTON,TX 77030
[3] UNIV TEXAS,HSC,HOUSTON,TX 77025
[4] BIOGENEX,SAN RAMON,CA
来源：
LABORATORY INVESTIGATION | 1993年 / 68卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A115 / A115
页数：1
相关论文
共 50 条
  • [21] Virological response and predictive factors for antiviral treatment in chronic HBV-related liver disease with low ALT and high HBV DNA
    Ma, Lei
    Li, Yan
    Weng, Lihan
    Xing, Huichun
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [22] The impact of recipient age on the effects of umbilical cord mesenchymal stem cells on HBV-related acute-on-chronic liver failure and liver cirrhosis
    Ka Zhang
    Haixia Sun
    Huijuan Cao
    Yifan Jia
    Xin Shu
    Hong Cao
    Yufeng Zhang
    Xiaoan Yang
    Stem Cell Research & Therapy, 12
  • [23] Significant Association Between Foxp3 Gene Polymorphism and Outcomes in HBV-Related Liver Transplant Patients
    Tanaka, Y.
    Sapana, V.
    Ohdan, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [24] The impact of recipient age on the effects of umbilical cord mesenchymal stem cells on HBV-related acute-on-chronic liver failure and liver cirrhosis
    Zhang, Ka
    Sun, Haixia
    Cao, Huijuan
    Jia, Yifan
    Shu, Xin
    Cao, Hong
    Zhang, Yufeng
    Yang, Xiaoan
    STEM CELL RESEARCH & THERAPY, 2021, 12 (01)
  • [25] Association between Recipient IL-15 Genetic Variant and the Prognosis of HBV-Related Hepatocellular Carcinoma after Liver Transplantation
    Zhang, Tao
    Liu, Yuan
    Peng, Xu
    Fan, Junwei
    Peng, Zhihai
    DISEASE MARKERS, 2017, 2017
  • [26] THE CHANGES OF ANTIERYTHROCYTE TITERS IN GROUP-O RECIPIENT FOLLOWING ABO MISMATCHED LIVING-RELATED LIVER-TRANSPLANT
    HASHIMOTO, T
    SHIMIZU, Y
    YAMAMORI, N
    OTOBE, Y
    SUZUKI, T
    NAKAMURA, Y
    ITOH, K
    HANAI, T
    MANABE, T
    HEPATOLOGY, 1994, 20 (04) : A355 - A355
  • [27] Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative
    Wang, Kai
    Jiang, Guomin
    Jia, Zhongzhi
    Zhu, Xiaoli
    Ni, Caifang
    MEDICINE, 2018, 97 (22)
  • [28] Perioperative entecavir for patients with HBV-related hepatocellular carcinoma and low levels of viral DNA: analysis using propensity score matching
    Yuan, Bao-Hong
    Li, Ru-Hong
    Yuan, Wei-Ping
    Xiang, Bang-De
    Zheng, Ming-Hua
    Yang, Tian
    Zhong, Jian-Hong
    Li, Le-Qun
    ONCOTARGET, 2017, 8 (31) : 51810 - 51816
  • [29] Intrahepatic covalently closed circular DNA (CCC DNA) detection in patients transplanted for HBV-related cirrhosis: A tool to judge for HBIG prophylaxis withdrawal in low-risk transplant recipients?
    Lenci, Floria
    Tisone, Giuseppe
    Ciotti, Marco
    Di Paolo, Daniele
    Tariciotti, Laura
    Marcuccilli, Fobio
    Perno, Carlo F.
    Angelico, Mario
    HEPATOLOGY, 2007, 46 (04) : 469A - 470A
  • [30] One-year vaccination against hepatitis B virus with a MPL-vaccine in liver transplant patients for HBV-related cirrhosis
    Di Paolo, Daniele
    Lenci, Ilaria
    Cerocchi, Carlo
    Tariciotti, Laura
    Monaco, Andrea
    Brega, Arianna
    Lotti, Laura
    Tisone, Giuseppe
    Angelico, Mario
    TRANSPLANT INTERNATIONAL, 2010, 23 (11) : 1105 - 1112
12345